glp 1 saxenda First Generic GLP-1 Injection OK'd for Weight Loss Teva introduces generic Saxenda |
Description
The secondary outcome was all-cause mortality
As a result, a full risk-of-bias assessment could not be performed
Widely prescribed and wildly popular, particularly for the unprecedented weight loss they confer, theyve shown promise in myriad organ systems
That said, a slight numerical imbalance of pancreatitis cases has been observed in some trials (for example, 13 vs 5 cases in LEADER trial over ~4 years, not significant)
However, as with other peptide systems discussed in this review, such variability often reflects limitations in measurement, context, or study design rather than the absence of biological relevance
